69 Best Cambridge Startups to Watch in 2024
How do we build this list? TLDR: Using math and experts.
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
Sign up to Seedtable Intel to access the entire database
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Silicon-free chip maker. |
$228M · Series D | Latitude, UK Infrastructure Bank, MVolution Partners | 101 to 250 | Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@pragmaticsemi.com | |
Bioinformatics discovery platform. |
$8M · Series A | Future Fund | 1 to 10 | Biotech, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@plaquetec.com | |
Surgical robotic system for minimal access surgery. |
$164M · Series D | SoftBank Group, Tencent, ABB Technology Ventures | 501 to 1000 | Health Tech, Robotics | B2B | Cambridge, UK | •••••••••••@cmrsurgical.com | |
Industrial diagnostic testing platform. |
$2M · Seed | Innovate UK | 1 to 10 | Health Tech | B2B | Cambridge, UK | •••••••••••@fuse-dx.com | |
AI-powered investment analytics platform. |
$6M · Series A | Fidelity International Strategic Ventures, Unusual Ventures, Clocktower Technology Ventures | 1 to 10 | AI, Investing | B2B, SaaS | Cambridge, UK | •••••••••••@theiainsights.com | |
Imaging analytics platform that processes and analyzes medical images. |
$8M · Series A | Ascension Ventures, Guinness Ventures, Hargreave Hale Aim VCT | 1 to 10 | Health Tech, Machine Learning, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@qureight.com | |
Platform for discovering new drugs for rare diseases using AI technology. |
$56M · Series B | Balderton Capital, Atomico, btov Partners | 51 to 100 | Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@healx.io | |
Cultured meat manufacturer. |
$30M · Series A | Balderton Capital, Lowercarbon Capital | 11 to 50 | Climate Tech & Green Tech, Foodtech | Cambridge, UK | •••••••••••@uncommonbio.co | ||
Human microbiome therapeutics developer creating live bacterial treatments and biomarkers. |
$66M | Seventure Partners, Cambridge Innovation Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
AI platform to advance precision medicine clinical trials. |
$11M · Series A | Seedcamp, Plural, Episode 1 | 11 to 50 | Health Tech, Biotech | B2B, SaaS | Cambridge, UK | •••••••••••@sanogenetics.com | |
Drug delivery platform. |
$24M · Series A | 4BIO Capital, UCB Ventures, Business Growth Fund | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@vianautis.com | ||
Transforming mental healthcare by unlocking the power of clinical data |
$52M · Series B | Molten Ventures | 101 to 250 | Health Tech, Deep Tech | B2B, B2C | Cambridge, UK | •••••••••••@iesogroup.com | |
Cybersecurity platform providing cloud-native logging and security analytics for organizations. |
$100M | Bessemer Venture Partners, Kibo Ventures, Insight Venture Partners | 251 to 500 | Cybersecurity, Data and Analytics, Privacy and Security, Business Intelligence, Developer Tools, Cloud | B2B, SaaS | Cambridge, UK | •••••••••••@devo.com | |
Cubic-GaN technology designed for efficient, low-cost LEDs leveraging proprietary intellectual property. |
$1M · Seed | FOV Ventures, Development Bank of Wales | Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@kubos-semi.com | ||
Small molecule neoantigen immuno-oncology therapies developer. |
$12M · Series B | Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management | 1 to 10 | Health Tech | Cambridge, UK | •••••••••••@neophore.com | ||
Climate analytics and risk assessement. |
$26M · Series B | IQ Capital Partners | 11 to 50 | Data and Analytics, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@risilience.com | |
Genomic data analysis platform. |
$2M · Seed | We Venture Capital, Nina Capital, LinkedIn | 11 to 50 | Biotech, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@zettagenomics.com | |
AI-driven visual content moderation platform. |
$15M · Series A | January Ventures, Creandum, Plural | 11 to 50 | AI, Sales and Marketing | B2B, SaaS | Cambridge, UK | •••••••••••@unitary.ai | |
Medical technology improving breast cancer care through magnetic sensing innovations. |
$20M · Series D | Molten Ventures | 51 to 100 | Health Tech, Hardware | B2B | Cambridge, UK | •••••••••••@endomag.com | |
DNA synthesis technology researcher. |
$24M · Series B | Foresite Capital | 11 to 50 | Biotech | Cambridge, UK | •••••••••••@evonetix.com | ||
Genomics company building safer cell and gene therapies. |
$15M · Series A | Tencent, Illumina Ventures | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@brokenstringbio.com | ||
Desktop technology making biology accessible by synthesizing proteins and genes. |
$42M · Series B | Future Planet Capital, Amadeus Capital, Verve Ventures | 11 to 50 | Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@nuclera.com | |
Telecommunications company developing end-to-end quantum cryptography systems. |
$7M · Seed | Expeditions Fund, Amadeus Capital, IQ Capital Partners | 1 to 10 | Hardware, Cybersecurity, Manufacturing, Communications | B2B | Cambridge, UK | •••••••••••@nu-quantum.com | |
Platform enabling the development of cell therapies through advanced reprogramming techniques. |
$10M · Series A | Astellas Venture Management, Parkwalk Advisors, Ahren Innovation Capital | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
Anti-cancer drug developer. |
$28M · Series A | Syncona Partners LLP, Cambridge Innovation Capital | 101 to 250 | Biotech | Cambridge, UK | •••••••••••@mosaic-tx.com | ||
Machine learning for automotive innovators |
$16M · Series A | Amadeus Capital, Cambridge Innovation Capital, Atlantic Bridge | 51 to 100 | AI | Cambridge, UK | •••••••••••@secondmind.ai | ||
Contract Research Organization specializing in bioscience research services. |
$4M · Series A | Gresham House Ventures, NPIF Maven Equity Finance | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@metrionbiosciences.com | ||
"Biotechnology platform producing sugar substitutes." |
$24M | Khosla Ventures, Felicis Ventures, Y Combinator | 11 to 50 | Health Tech, Foodtech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@supplant.com | |
Platform for understanding and defining the biological codes that make up human cells. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
Physiological upregulation therapy to treat neurodegenerative diseases. |
$5M · Seed | SV Health Investors | 11 to 50 | Health Tech, Biotech | Cambridge, UK | •••••••••••@harnesstx.com | ||
Transistors designed to integrate GaN technology into everyday consumer electronics. |
$19M | IQ Capital Partners, Cambridge Innovation Capital, Business Growth Fund | 11 to 50 | Manufacturing | B2B | Cambridge, UK | •••••••••••@camgandevices.com | |
Precision software for surgeries. |
$11M · Series A | Pembroke VCT | 11 to 50 | Health Tech | B2B, SaaS | Cambridge, UK | •••••••••••@cydarmedical.com | |
Platform for helping people navigate end-of-life. |
$14M | Creandum, Headline | 1 to 10 | Health Tech, Mobile, Mobility & Transportation, Manufacturing, Sales and Marketing | B2C | Cambridge, UK | •••••••••••@joincake.com | |
Database specializing in space-time analytics, providing rapid insights at a fraction of the cost. |
$5M | Parkwalk Advisors | 11 to 50 | Climate Tech & Green Tech, Fintech, Mobile, Data and Analytics, Business Intelligence, Internet of Things, Developer Tools, Cloud | B2B, SaaS | Cambridge, UK | •••••••••••@geospock.com | |
Flow sensor technology focused on creating the world's smallest device. |
$5M · Series A | Parkwalk Advisors, Martlet Capital | 11 to 50 | Navigation and Mapping, Manufacturing | B2B | Cambridge, UK | •••••••••••@flussoltd.com | |
Pharmacy service that combines caring customer support with modern technology for a personalized experience. |
$6M · Seed | Hoxton Ventures | 11 to 50 | Health Tech, CPG & Consumer Goods, Pharma, Ecommerce | B2B, B2C, SaaS | Cambridge, UK | •••••••••••@pillsorted.com | |
Developer of high-powered battery technology for automotive applications. |
$10M · Series A | IQ Capital Partners | 11 to 50 | Climate Tech & Green Tech, Energy & Nuclear, Manufacturing | B2B | Cambridge, UK | •••••••••••@nyobolt.com | |
Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications. |
$5M · Series B | Parkwalk Advisors, Downing Ventures | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@qkine.com | ||
Platform that helps manage and analyze life sciences data for organizations. |
$3M · Seed | ETF Partners, Granpool Innovative Investments | 11 to 50 | Health Tech, Biotech | B2B | Cambridge, UK | •••••••••••@eaglegenomics.com | |
Biodiversity measurement platform. |
$5M · Seed | Octopus Ventures | 11 to 50 | Climate Tech & Green Tech | Cambridge, UK | •••••••••••@pivotal.earth | ||
Quantum error correction solutions provider. |
$75M · Series C | Molten Ventures, Amadeus Capital, Planet First Partners | 51 to 200 | Quantum Computing | B2B, SaaS | Cambridge, UK | •••••••••••@riverlane.com | |
Live human cell cultures and genome editing services for researchers. |
$5M | Calculus Capital | 11 to 50 | Health Tech, Biotech, Pharma, Business Intelligence | B2B | Cambridge, UK | •••••••••••@axolbio.com | |
Cancer immunotherapeutics company working across the Atlantic. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Supplier of configurable process node agnostic analog IP building blocks. |
$5M · Seed | Omers Ventures, Firstminute Capital, MMC Ventures | 11 to 50 | Deep Tech, Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@agileanalog.com | |
Cancer diagnostics. |
$16M · Series A | Business Growth Fund | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cyted.ai | ||
AI-driven tech for respiratory conditions. |
$9M · Series A | Business Growth Fund, Downing Ventures | 11 to 50 | Health Tech, AI | Cambridge, UK | •••••••••••@tidalsense.com | ||
Semiconductor developer. |
$8M · Series A | Business Growth Fund | 11 to 50 | Hardware, Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@forefrontrf.com | |
Drug manufacturer. |
$10M · Series A | Biospring Partners | 501 to 1000 | Health Tech, Biotech, Pharma | B2B, SaaS | Cambridge, UK | •••••••••••@abzena.com | |
Fibroblast technology designed to develop new therapies for diseases. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
Deubiquitylating enzyme (DUB) drug discovery and development platform. |
$6M · Series A | Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments | 51 to 100 | Health Tech, Biotech | Cambridge, UK | •••••••••••@missiontherapeutics.com | ||
Pet therapeutics startup dedicated to developing medicines for pets. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Software offering autonomous speech and voice recognition for live and recorded media. |
$8M · Series A | AlbionVC, IQ Capital Partners | 101 to 250 | Music and Audio, Data and Analytics, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@speechmatics.com | |
Platform offering secure, over-the-air updatable software for embedded product development. |
$8M · Series A | BACKED VC, Crane Venture Partners, IQ Capital Partners | 11 to 50 | B2B, SaaS | Cambridge, UK | •••••••••••@foundries.io | ||
Breathalyzer technology for non-invasive detection of infectious diseases. |
$57M · Series D | 101 to 250 | Health Tech | Cambridge, UK | •••••••••••@owlstonemedical.com | |||
Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw. |
$88M · Series D | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cambridge-epigenetix.com | |||
Setting the standard for Salesforce DevOps |
$55M | 101 to 250 | Sales and Marketing, Developer Tools | B2B, SaaS | Cambridge, UK | •••••••••••@gearset.com | ||
Independent biotech company focused on developing new cancer therapies targeting DNA damage response. |
$152M · Series C | 101 to 250 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@artiospharma.com | |||
Biological sensor enabling quick and affordable detection of biological substances. |
$2M · Seed | Parkwalk Advisors | 1 to 10 | Hardware, Biotech, Manufacturing, Business Intelligence | B2B | Cambridge, UK | •••••••••••@hexagonfab.com | |
Platform utilizing microfabrication technology to create smart materials for innovative cell testing. |
$2M · Seed | Parkwalk Advisors, Martlet Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@semarion.com | |
Manufacturer of autonomous harvesting robots. |
$1M · Seed | Elbow Beach Capital | 1 to 10 | Robotics, Manufacturing | B2B | Cambridge, UK | •••••••••••@fieldworkrobotics.com | |
Platform specializing in single cell analysis and characterization, offering related R&D services. |
$4M | Sofinnova Partners | 11 to 50 | Health Tech, Deep Tech | B2B | Cambridge, UK | •••••••••••@spherefluidics.com | |
Social multi-player gaming studio. |
$4M · Series A | Makers Fund | 1 to 10 | Foodtech, Gaming, CPG & Consumer Goods, Consumer Social, Community & Lifestyle | B2C | Cambridge, UK | •••••••••••@worldmakers.com | |
Plant-based biodegradable material producer. |
$2M · Seed | Amadeus Capital, Horizons Ventures, Parkwalk Advisors | 1 to 10 | Biotech | B2B | Cambridge, UK | •••••••••••@xampla.com | |
Platform helping Producer Groups improve their agri-food supply chains. |
$4M · Series A | Notion Capital, IQ Capital Partners | 11 to 50 | Climate Tech & Green Tech, Agritech | B2B, SaaS | Cambridge, UK | •••••••••••@kisanhub.com | |
Cloud-based computing platform. |
$3M · Seed | IQ Capital Partners, Creator Fund | 11 to 50 | Hardware, Manufacturing | B2B | Cambridge, UK | •••••••••••@signaloid.ai | |
Platform for identifying and sourcing specialist expertise globally using AI technology. |
$4M · Series A | Nauta Capital, Business Growth Fund | 51 to 100 | AI, Business Intelligence | B2B, SaaS, Marketplace | Cambridge, UK | •••••••••••@techspert.com | |
Generative AI platform for law firms. |
$3M · Seed | Talis Capital, National Grid Partners (NGP), March Capital | 101 to 250 | AI, Legal Tech | B2B, SaaS | Cambridge, UK | •••••••••••@luminance.com | |
Novel cancer therapies. |
$30M · Series B | 11 to 50 | Health Tech, Deep Tech | B2C | Cambridge, UK | •••••••••••@stormtherapeutics.com | ||
Drug discovery company based in Cambridge, UK. |
$45M · Series B | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@phoremost.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with – 205 in Cambridge.